Consult
Log In
Menu
Consult
Log in
thr3-eyes-168518-unsplash-463127-edited
Cara Cheasick

Cara Cheasick

Regional Vice President of Commercial Development

Cara joins PierianDx from Illumina where she managed all aspects of the clinical business for accounts in
several states in the midwest and worked with customers in clinical laboratories using NGS and microarray technologies. Her role at Illumina included promoting the PierianDx solution through the Illumina-PierianDx partnership and it was through this experience that Cara gained greater insight into the challenge laboratories face in analyzing, interpreting and reporting on NGS data in their Precision Medicine programs and how she became interested in helping customers solve the challenges they are facing in this part of the clinical NGS workflow.

Cara has an extensive and successful background in the Life Sciences industry. Her career began in the
field of nucleic acid isolation where she led the Technical Services team at Gentra (acquired by Qiagen)
for over 10 years. From there she moved to Roche Life Sciences where she held positions on the sales
and sales leadership teams and provided qPCR, 454 Sequencing, and other Roche Life Science
technologies to NCI Cancer Centers, academic laboratories, reference labs and pharma. After her 6+
years at Roche, Cara joined Asuragen where she led a team selling both FDA-cleared and RUO assays to clinical laboratories.

Cara graduated from the University of Minnesota with a B.S. in Microbiology.

I’m passionate about helping clinical laboratories provide the most accurate answers and information to the physicians and patients they serve and enabling them to do so with best-in-class technologies like the PierianDx Clinical Genomics Workspace and Knowledgebase."